Skip to main content
OpenTrials

Clinical trial condition

Motor Neuron Disease

Explore clinical trials studying Motor Neuron Disease. Study availability and eligibility vary by location and protocol.

155 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Motor Neuron Disease trial results

Completed

Phase 3 Study of Dexpramipexole in ALS

NCT01281189

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Barrow Neurological Institute - St. Joseph's Hospital Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California at San Francisco - Fresno Fresno, California, United States
  • University of California, Irvine Orange, California, United States
View all 82 locations
View Trial Details
Completed

MRI Biomarkers in ALS

NCT02405182

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +10 more
Locations
  • University of Calgary / Heritage Medical Research Clinic Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • University of British Columbia / GF Strong Rehab Centre Vancouver, British Columbia, Canada
  • Western University / London Health Sciences Centre London, Ontario, Canada
View Trial Details
Completed

Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis

NCT01605006

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +14 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • California Pacific Medical Center -- Forbes Norris MDA/ALS Research Center San Francisco, California, United States
  • University of Colorado Denver Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View Trial Details
Completed

Answer ALS: Individualized Initiative for ALS Discovery

NCT02574390

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophy, monomelic, Asymptomatic ALS Gene Carriers, +20 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

A Trial of Tocilizumab in ALS Subjects

NCT02469896

Conditions
ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +10 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Wake Forest University School of Medicine Winston-Salem, North Carolina, United States
View Trial Details

Related conditions